SphingoTec GmbH

SphingoTec GmbH operates as a biotechnology company. The Company develops biomarkers for diagnosis, prediction, and monitoring of acute medical conditions, such as acute heart failure, acute kidney injury, and circulatory shock to support patient management and guidance treatment strategies. SphingoTec serves customers in Germany.